Kirkland Represents LAV in Successful Closing of Seventh Life Sciences Fund

Kirkland & Ellis advised LAV, a leading biomedical venture capital firm, on the final closing of its seventh USD life sciences fund, LAV Fund VII, L.P., at its hard cap. The fund was subscribed with a broad mix of global institutional investors, including sovereigns, pensions, endowments, foundations, family offices, large corporates and fund of funds. Kirkland also represented LAV on raising its predecessor funds, LAV Funds III, IV, V and VI.

The Kirkland team included investment funds lawyers Carol Liu, Yeshu Yang, Jennifer Feng and Nicole Yang; investment funds regulatory lawyers Josh Westerholm, Reed Schuster and Hannah Cloh; investment funds ERISA lawyer Sabrina Glaser; tax lawyers Dan Meehan, Ian Ferreira, Andrew Chan, Florian Schütte and Shiyu Ni; financial services regulatory lawyer Adam Skinner; and international trade & national security lawyers Luci Hague and Billy Phalen.